FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yves Laurian

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Blood Transfusions

Co-author Network

Publications

TOP 3
Audrey Toledano; Eric Lachassinne; Claire Roumegoux; Yves Laurian; Zahira Benabadji; Fouad Chiadmi; salvatore cisternino; Joël Schlatter; Jean-Eudes FONTAN
Treatment of congenital afibrinogenemia in a premature neonate.
Clément d'Audigier; Eric Pasmant; Odile Bournier; Yves Laurian; Marie-Claude Guillin; Annie Bezeaud
A natural variant with a point mutation resulting in a homozygous Arg to His substitution at position 388 in prothrombin.
Thierry Calvez; Yves Laurian; Jenny Goudemand
Inhibitor incidence with recombinant vs. plasma-derived FVIII in previously untreated patients with severe hemophilia A: homogeneous results from four published observational studies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yves Laurian (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Audrey Toledano; Eric Lachassinne; Claire Roumegoux; Yves Laurian; Zahira Benabadji; Fouad Chiadmi; salvatore cisternino; Joël Schlatter; Jean-Eudes FONTAN
Treatment of congenital afibrinogenemia in a premature neonate.
The Annals of pharmacotherapy 2008;42(7):1145-6.
2008: Clément d'Audigier; Eric Pasmant; Odile Bournier; Yves Laurian; Marie-Claude Guillin; Annie Bezeaud
A natural variant with a point mutation resulting in a homozygous Arg to His substitution at position 388 in prothrombin.
Haematologica 2008;93(5):799-800.
2008: Thierry Calvez; Yves Laurian; Jenny Goudemand
Inhibitor incidence with recombinant vs. plasma-derived FVIII in previously untreated patients with severe hemophilia A: homogeneous results from four published observational studies.
Journal of thrombosis and haemostasis : JTH 2008;6(2):390-2.
2007: Thierry Calvez; Yves Laurian; Jenny Goudemand
Associations between type of product and inhibitors in previously untreated patients (PUPs) with severe hemophilia: switches and particular products can disturb analysis.
Blood 2007;110(3):1073-4; author reply 1074-5.
2006: Jenny Goudemand; Yves Laurian; Thierry Calvez
Risk of inhibitors in haemophilia and the type of factor replacement.
Current opinion in hematology 2006;13(5):316-22.
2006: Benoît Guillet; Thierry Lambert; Roseline d'Oiron; VALERIE PROULLE; Jean-Luc Plantier; Anne Rafowicz; Jocelyne Peynet; Jean-Marc Costa; Laurence Bendelac; Yves Laurian; Jean-Maurice Lavergne
Detection of 95 novel mutations in coagulation factor VIII gene F8 responsible for hemophilia A: results from a single institution.
Human mutation 2006;27(7):676-85.
2006: Thierry Calvez; Yves Laurian
Protective effect of prophylaxis on inhibitor development in children with haemophilia A: more convincing studies are required.
British journal of haematology 2006;132(6):798-800; author reply 800-1.
2006: Jenny Goudemand; Chantal Rothschild; Virginie Demiguel; Christine Vinciguerrat; Thierry Lambert; Hervé Chambost; Annie Borel-Derlon; Ségolène Claeyssens; Yves Laurian; Thierry Calvez
Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A.
Blood 2006;107(1):46-51.
2002: Isabelle Martin; Fayçal Kriaa; VALERIE PROULLE; Benoît Guillet; Cécile Kaplan; Roseline d'Oiron; Marianne Debré; Edith Fressinaud; Yves Laurian; Gil Tchernia; Bernard Charpentier; Thierry Lambert; Marie Dreyfus
Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodies.
British journal of haematology 2002;119(4):991-7.
2001: Benoît Guillet; Fayçal Kriaa; M G Huysse; VALERIE PROULLE; C George; Gil Tchernia; Roseline d'Oiron; Yves Laurian; B Charpentier; Thierry Lambert; Marie Dreyfus
Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophilia.
British journal of haematology 2001;114(4):837-44.
2001: Thierry Calvez; M Biou; D Costagliola; A M Jullien; Yves Laurian; F Rossi; Chantal Rothschild; P Sié
The French haemophilia cohort: rationale and organization of a long-term national pharmacosurveillance system.
Haemophilia : the official journal of the World Federation of Hemophilia 2001;7(1):82-8.
2000: Gérard Benoit; Thierry Lambert; Pascal Blanchet; Yves Laurian; P Lasjaunias; Roseline d'Oiron; Pascal Eschwege; J Langloys; Stéphane Droupy; Fayçal Kriaa; Alain Jardin
[Which urologic treatment alternatives are there for the hemophiliac patient?].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2000;10(3):388-96.
2000: Roseline d'Oiron; C Ménart; Marie C Trzeciak; Paquita Nurden; Edith Fressinaud; Marie Dreyfus; Yves Laurian; Claude Négrier
Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures.
Thrombosis and haemostasis 2000;83(5):644-7.
1999: Armelle Parquet; Yves Laurian; Chantal Rothschild; R Navarro; C Guérois; Valerie Gay; Anne Durin; Jocelyne Peynet; Y Sultan
Incidence of factor IX inhibitor development in severe haemophilia B patients treated with only one brand of high purity plasma derived factor IX concentrate.
Thrombosis and haemostasis 1999;82(4):1247-9.
1998: Chantal Rothschild; Yves Laurian; E P Satre; Annie Borel-Derlon; Hervé Chambost; P Moreau; Jenny Goudemand; Armelle Parquet; Jocelyne Peynet; M Vicariot; P Beurrier; Ségolène Claeyssens; Anne Durin; Albert Faradji; Edith Fressinaud; S Gaillard; V Guérin; C Guérois; Gilles Pernod; P Pouzol; Jean-François Schved; C Gazengel
French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII : incidence of inhibitor and evaluation of immune tolerance.
Thrombosis and haemostasis 1998;80(5):779-83.
1998: Jean-Pierre Girma; Edith Fressinaud; Anne Houllier; Yves Laurian; Jean Amiral; Dominique Meyer
Assay of factor VIII antigen (VIII:CAg) in 294 haemophilia A patients by a new commercial ELISA using monoclonal antibodies.
Haemophilia : the official journal of the World Federation of Hemophilia 1998;4(2):98-103.
1996: Charles R M Hay; Yves Laurian
Induction of tolerance using porcine factor VIII.
Vox sanguinis 1996;70 Suppl 1():68-9.
1995: Stylianos Antonarakis; Judith P. Rossiter; M Young; J Horst; P de Moerloose; S S Sommer; Rhett P Ketterling; Haig Kazazian ; Claude Négrier; Christine Vinciguerra; Jane Gitschier; Michel Goossens; Emmanuelle Girodon; N Ghanem; F Plassa; Jean-Maurice Lavergne; M Vidaud; J M Costa; Yves Laurian; S W Lin; S R Lin; M C Shen; David Lillicrap; S A Taylor; S Windsor; Sophie Valleix; Khedoudja Nafa; Y Sultan; Marc Delpech; C L Vnencak-Jones; J A Phillips; R C Ljung; E Koumbarelis; AE Gialeraki; Titika Mandalaki; P Vincent Jenkins; P W Collins; K John Pasi; Anne C Goodeve; Ian R Peake; F Eric Preston; Marianne Schwartz; E Scheibel; Jørgen Ingerslev; D N Cooper; D S Millar; V V Kakkar; F Giannelli; J A Naylor; E F Tizzano; Montserrat Baiget; M Domenech; Carme Altisent; J Tusell; M Beneyto; J I Lorenzo; Christine Gaucher; Claudine Mazurier; Kathelijne Peerlinck; Gert Matthijs; J J Cassiman; J Vermylen; Pier Giorgio Mori; M Acquila; Daniela Caprino; H Inaba
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study.
Blood 1995;86(6):2206-12.
1995: C Guérois; Yves Laurian; Chantal Rothschild; A Parquet-Gernez; A M Duclos; Claude Négrier; M Vicariot; Béatrice Fimbel; Edith Fressinaud; M Fiks-Sigaud
Incidence of factor VIII inhibitor development in severe hemophilia A patients treated only with one brand of highly purified plasma-derived concentrate.
Thrombosis and haemostasis 1995;73(2):215-8.
1994: Yves Laurian; E Dussaix; Armelle Parquet; A Chalvon-Demersay; R d'Oiron; G Tchernia
Transmission of human parvovirus B19 by plasma derived factor VIII concentrates.
Nouvelle revue française d'hématologie 1994;36(6):449-53.
1993: M Tartary; D Vidaud; Y Piao; J M Costa; B R Bahnak; Edith Fressinaud; B Congard; Yves Laurian; D Meyer; Jean-Maurice Lavergne
Detection of a molecular defect in 40 of 44 patients with haemophilia B by PCR and denaturing gradient gel electrophoresis.
British journal of haematology 1993;84(4):662-9.
1993: T Sahmoud; Yves Laurian; C Gazengel; Y Sultan; C Gautreau; D Costagliola
Progression to AIDS in French haemophiliacs: association with HLA-B35.
AIDS (London, England) 1993;7(4):497-500.
1993: D Vidaud; M Vidaud; B R Bahnak; Virginie Siguret; S Gispert Sanchez; Yves Laurian; D Meyer; Michel Goossens; Jean-Maurice Lavergne
Haemophilia B due to a de novo insertion of a human-specific Alu subfamily member within the coding region of the factor IX gene.
European journal of human genetics : EJHG 1993;1(1):30-6.
1992: P Maisonneuve; A M Couroucé; F Ferrer le Coeur; C Guérois; Yves Laurian; M Magniez; A Parquet-Gernez; F Verroust; L Noël
[Anti-HCV and recipients: situation in hemophiliacs in 1991].
Revue française de transfusion et d'hémobiologie : bulletin de la Société nationale de transfusion sanguine 1992;35(3):193-8.
1992: Jean-Maurice Lavergne; B R Bahnak; M Vidaud; Yves Laurian; D Meyer
A directed search for mutations in hemophilia A using restriction enzyme analysis and denaturing gradient gel electrophoresis. A study of seven exons in the factor VIII gene of 170 cases.
Nouvelle revue française d'hématologie 1992;34(1):85-91.
1991: J P Allain; S H Dailey; Yves Laurian; D S Vallari; A Rafowicz; Suresh M Desai; Sushil G Devare
Evidence for persistent hepatitis C virus (HCV) infection in hemophiliacs.
The Journal of clinical investigation 1991;88(5):1672-9.
1991: C Guerois; Armelle Parquet; M Vicariot; F F Lecoeur; P Maisonneuve; A M Courouce; F Dubois; Yves Laurian
[Efficacy in viral inactivation of the concentrates of factor VIII and IX by the solvent/detergent procedure. Evaluation in patients with hemophilia].
Presse médicale (Paris, France : 1983) 1991;20(25):1163-6.
1991: Jean-Maurice Lavergne; Yves Laurian; A Dudilleux; M J Larrieu; B R Bahnak; D Meyer
Carrier detection and prenatal diagnosis in 98 families of haemophilia A by linkage analysis and direct detection of mutations.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1991;2(2):293-301.
1991: P Maisonneuve; Yves Laurian; C Guerois; F Verroust; F Ferrer Le Coeur; A M Couroucé; L Noel
Antibody to hepatitis C (anti C 100-3) in French hemophiliacs.
Nouvelle revue française d'hématologie 1991;33(3):263-6.
1990: P Maisonneuve; Yves Laurian; L Noël; C Guérois; I Assouvie-Gomez; F Ferrer-Le Coeur; F Verroust; A M Couroucé; B Saint-Paul
[Antibodies against hepatitis C virus in French hemophiliacs].
Revue française de transfusion et d'hémobiologie : bulletin de la Société nationale de transfusion sanguine 1990;33(5):375-7.
1990: Charles R M Hay; Yves Laurian; F Verroust; F E Preston; P B Kernoff
Induction of immune tolerance in patients with hemophilia A and inhibitors treated with porcine VIIIC by home therapy.
Blood 1990;76(5):882-6.
1989: Yves Laurian; J Peynet; F Verroust
HIV infection in sexual partners of HIV-seropositive patients with hemophilia.
The New England journal of medicine 1989;320(3):183.
1988: P Y Venencie; C Foldès; Yves Laurian; F Lemarchand-Venencie; D Lemay; F Verroust
Erythema dyschromicum perstans following human immunodeficiency virus seroconversion in a child with hemophilia B.
Archives of dermatology 1988;124(7):1013-4.
1987: J P Allain; Yves Laurian; D A Paul; F Verroust; M Leuther; C Gazengel; D Senn; M J Larrieu; C Bosser
Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia. Potential clinical importance.
The New England journal of medicine 1987;317(18):1114-21.
1987: F Verroust; D Lemay; Yves Laurian
High frequency of herpes zoster in young hemophiliacs.
The New England journal of medicine 1987;316(3):166-7.
1986: J P Allain; Yves Laurian; D A Paul; D Senn
Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs.
Lancet 1986;2(8518):1233-6.
1986: Yves Laurian; P Le Bras; A Ellrodt; P Alvin
Immune thrombocytopenia gammaglobulin, and positivity to the human T-lymphotropic virus type III.
Annals of internal medicine 1986;105(1):145-6.
1986: F Pichot; B Bader; Yves Laurian; P Alvin; M Tardieu; G Tchernia; M J Larrieu; V Courtecuisse
[Acquired immunodeficiency syndrome in an adolescent hemophiliac].
Archives françaises de pédiatrie 1986;43(5):341-4.
1984: Yves Laurian; T Lambert; M J Larrieu
[Acquired immunodeficiency syndrome and related syndromes in hemophiliacs: status throughout the world].
Revue française de transfusion et immuno-hématologie 1984;27(4):493-6.
1984: Yves Laurian; Jean-Pierre Girma; T Lambert; D Meyer; M J Larrieu
Incidence of immune responses following 102 infusions of autoplex in 18 hemophilic patients with antibody to factor VIII.
Blood 1984;63(2):457-62.
1984: J P Allain; W Duermeijer; J A Hellings; C Gazengel; Yves Laurian; F Verroust
Non-A, non-B hepatitis in hemophilic patients with inhibitor treated with activated prothrombin complex concentrates: lack of correlation with an antigen possibly related to non-A, non-B hepatitis.
Vox sanguinis 1984;47(1):47-53.
1982: Yves Laurian; Jean-Pierre Girma; J P Allain; F Verroust; M J Larrieu
Absence of anamnestic response after transfusion of washed red blood cells in haemophilia A patients with antibody to factor VIII.
Scandinavian journal of haematology 1982;28(3):233-7.